ASPECCT: A Study of Panitumumab Efficacy and Safety Compared to Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer

Name: ASPECCT: A Study of Panitumumab Efficacy and Safety Compared to Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer
Published: 2010
License: Public Domain

Amgen · 2010

ClinicalTrials.gov · Datasets · License: Public Domain · 2010

Open Source ↗

colon-cancer colorectal-cancer rectal-cancer

metastatic colorectal cancer, panitumumab, vectibix, colon cancer, colorectal cancer, rectal cancer, cetuximab, erbitux, metastatic, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

ASPECCT: A Study of Panitumumab Efficacy and Safety Compared to Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer

Related documents